2020
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses
Wallach JD, Wang K, Zhang AD, Cheng D, Grossetta Nardini HK, Lin H, Bracken MB, Desai M, Krumholz HM, Ross JS. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. The BMJ 2020, 368: l7078. PMID: 32024657, PMCID: PMC7190063, DOI: 10.1136/bmj.l7078.Peer-Reviewed Original ResearchConceptsIndividual patient-level dataCardiovascular related deathsCardiovascular riskMyocardial infarctionRelated deathsSummary-level dataHeart failureOdds ratioSystematic reviewIncreased cardiovascular riskMore myocardial infarctionsHeart failure eventsCochrane Central RegistryAcute myocardial infarctionMyocardial infarction eventsPatient-level dataRandom-effects modelWeb of ScienceAnalysis of trialsEligible trialsComposite outcomeAdverse eventsContinuity correctionControlled TrialsRosiglitazone treatment
2001
Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons
Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons. JAMA 2001, 285: 1971-1977. PMID: 11308433, DOI: 10.1001/jama.285.15.1971.Peer-Reviewed Original ResearchConceptsModerate alcohol consumptionHeart failureHeart failure ratesMyocardial infarctionAlcohol consumptionOlder personsNonfatal heart failure eventsHistory of MIHeart failure eventsProspective cohort studyHeart failure riskBody mass indexPopulation-based sampleCohort studyCurrent smokingMass indexMI riskPulse pressureFailure rateRelative riskAmount of alcoholMAIN OUTCOMELower riskElderly personsBaseline